Compugen Announces Development of NexGen Infrastructure Platform for Analysis of Next Generation Sequencing Data
Compugen Ltd. (NASDAQ: CGEN) announced today the development of “NexGen,” a new platform designed to significantly enhance Compugen’s overall infrastructure for predictive drug and drug target discovery. NexGen is designed to analyze Next Generation Sequencing data which is now beginning to be generated worldwide through RNA-Seq methodology.
to read the entire article. Please